Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 8191 AL 8205

Distinct effects of long-term Tai Chi Chuan and aerobic exercise interventions on motor and neurocognitive performance in early-stage Parkinson's disease: a randomized controlled trial

Chang CL, Lin TK, Pan CY, Wang TC, Tseng YT, Chien CY, Tsai CL.

Eur J Phys Rehabil Med. 2024 Aug;60(4):621-633. doi: 10.23736/S1973-9087.24.08166-8. Epub 2024 Jun 18.

Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson's disease

Jiang S, Wang H, Yang C, Feng F, Xu D, Zhang M, Xie M, Cui R, Zhu Z, Jia C, Liu L, Wang L, Yang X, Yang Y, Hao H, Liu Z, Wu Z, Leng L, Li X, Sun X, Zhao X, Xu J, Zhang Y, Wan X, Bao X, Wang R.

J Neurol Neurosurg Psychiatry. 2024 Nov 18;95(12):1102-1111. doi: 10.1136/jnnp-2023-332921.

Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial

Pagano G, Monnet A, Reyes A, Ribba B, Svoboda H, Kustermann T, Simuni T, Postuma RB, Pavese N, Stocchi F, Brockmann K, Smigorski K, Gerbaldo V, Fontoura P, Doody R, Kerchner GA, Brundin P, Marek K, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group.

Nat Med. 2024 Dec;30(12):3669-3675. doi: 10.1038/s41591-024-03270-6. Epub 2024 Oct 8.

Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial

McGarry A, Rosanbalm S, Leinonen M, Olanow CW, To D, Bell A, Lee D, Chang J, Dubow J, Dhall R, Burdick D, Parashos S, Feuerstein J, Quinn J, Pahwa R, Afshari M, Ramirez-Zamora A, Chou K, Tarakad A, Luca C, Klos K, Bordelon Y, St Hiliare MH, Shprecher D, Lee S, Dawson TM, Roschke V, Kieburtz K.

Lancet Neurol. 2024 Jan;23(1):37-45. doi: 10.1016/S1474-4422(23)00378-2.

On-Demand Cueing for Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial

Zoetewei D, Herman T, Ginis P, Palmerini L, Brozgol M, Thumm PC, Ferrari A, Ceulemans E, Decaluwé E, Hausdorff JM, Nieuwboer A.

Mov Disord. 2024 May;39(5):876-886. doi: 10.1002/mds.29762. Epub 2024 Mar 14.

Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

Espay AJ, Stocchi F, Pahwa R, Albanese A, Ellenbogen A, Ferreira JJ, Giladi N, Gurevich T, Hassin-Baer S, Hernandez-Vara J, Isaacson SH, Kieburtz K, LeWitt PA, Lopez-Manzanares L, Olanow CW, Poewe W, Sarva H, Yardeni T, Adar L, Salin L, Lopes N, Sasson N, Case R, Rascol O; BouNDless Study Group.

Lancet Neurol. 2024 May;23(5):465-476. doi: 10.1016/S1474-4422(24)00052-8. Epub 2024 Mar 15.

Short-Term Cannabidiol with Δ-9-Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial

Liu Y, Bainbridge J, Sillau S, Rajkovic S, Adkins M, Domen CH, Thompson JA, Seawalt T, Klawitter J, Sempio C, Chin G, Forman L, Fullard M, Hawkins T, Seeberger L, Newman H, Vu D, Leehey MA.

Mov Disord. 2024 May;39(5):863-875. doi: 10.1002/mds.29768. Epub 2024 Mar 15.

Long-Term Dementia Risk in Parkinson Disease

Gallagher J, Gochanour C, Caspell-Garcia C, Dobkin RD, Aarsland D, Alcalay RN, Barrett MJ, Chahine L, Chen-Plotkin AS, Coffey CS, Dahodwala N, Eberling JL, Espay AJ, Leverenz JB, Litvan I, Mamikonyan E, Morley J, Richard IH, Rosenthal L, Siderowf AD, Simuni T, York MK, Willis AW, Xie SX, Weintraub D; Parkinson's Progression Markers Initiative.

Neurology. 2024 Sep 10;103(5):e209699. doi: 10.1212/WNL.0000000000209699. Epub 2024 Aug 7.

Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial

Scheperjans F, Levo R, Bosch B, Lääperi M, Pereira PAB, Smolander OP, Aho VTE, Vetkas N, Toivio L, Kainulainen V, Fedorova TD, Lahtinen P, Ortiz R, Kaasinen V, Satokari R, Arkkila P.

JAMA Neurol. 2024 Sep 1;81(9):925-938. doi: 10.1001/jamaneurol.2024.2305.

Trial of Lixisenatide in Early Parkinson's Disease

Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group.

N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323.

Drug-induced parkinsonism: diagnosis and treatment

Conn H, Jankovic J.

Expert Opin Drug Saf. 2024 Dec;23(12):1503-1513. doi: 10.1080/14740338.2024.2418950. Epub 2024 Oct 25.

Variability of Maximum Glottal Angle on Clinical Sniff Task Differs in Patients With Functional and Organic Laryngeal Pathologies Compared to Healthy Controls

Welch B, Gold K, Gartner-Schmidt J, Petrov A, Law A, Helou LB.

J Voice. 2026 May;40(3):831-837. doi: 10.1016/j.jvoice.2023.12.007. Epub 2024 Jan 8.

BCL11B-Related Dystonia: Further Evidence of an Emerging Cause of Childhood-Onset Generalized Dystonia

Garone G, Capuano A, Amodio D, Nicita F, Travaglini L, Graziola F, De Benedictis A, Frascarelli F, Parisi P, Pizzi S, Tartaglia M, Marras CE, Niceta M.

Mov Disord Clin Pract. 2024 Jul;11(7):897-901. doi: 10.1002/mdc3.14084. Epub 2024 May 27.

Movement Disorder Perspectives on Monocarboxylate 8 Deficiency: A Case Series of 3 Colombian Patients with Allan-Herndon-Dudley Syndrome

Ramon-Gomez JL, Cortés-Rojas MC, Polania-Puentes MJ, Guerrero-Ruiz GDP.

Mov Disord Clin Pract. 2024 May;11(5):567-570. doi: 10.1002/mdc3.14009. Epub 2024 Mar 7.

The spectrum of movement disorders in young children with ARX-related epilepsy-dyskinesia syndrome

Akula SK, Quiroz V, D'Gama AM, Chiu MY, Koh HY, Saffari A, Zaman Z, Tam A, Srouji R, Valentine R, Wiltrout K, Pinto A, Harini C, Pearl PL, Poduri A, Ebrahimi-Fakhari D.

Ann Clin Transl Neurol. 2024 Jun;11(6):1643-1647. doi: 10.1002/acn3.52055. Epub 2024 May 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias